2836 – Page 65 – China Stock Advice

CBPO [China Biologic Products] 8-K: China Biologic Products Reports Higher Results for the

[China Biologic Products Reports Higher Results for the First Quarter 2012 Beijing, China, May 8, 2012 China Biologic Products, Inc. (NASDAQ: CBPO) (China Biologic or the Company), one of the leading plasma-based biopharmaceutical companies in the Peoples Republic of China (PRC), today reported higher financial results for the three months ended March 31, 2012 compared with the first quarter] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): May 8, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) 18th Floor, Jialong International Building (+86) 10-6598-3111 ____________________________________________________________ (Former name or former address, if changed since last report) see ITEM 2.02 RESULTS OF]

By info| 2016-04-03T02:05:04+00:00 May 9th, 2012|Categories: CBPO, Chinese Stocks, Webplus ver|Tags: 0001369868, 2012-05-09, 2836, 8-K, BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES), CBPO|0 Comments

CBPO [China Biologic Products] 10-Q: (Original Filing)

[FORM 10Q (Mark One) For the quarterly period ended: March 31, 2012 [ ] For the transition period from ____________to _____________ CHINA BIOLOGIC PRODUCTS, INC. Delaware 75-2308816 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) 18th Floor, Jialong International Building Chaoyang District, Beijing 100125 (+86) 10-6598-3111 _____________________________________________________________________ (Former name, former address and former fiscal year, if] [CERTIFICATIONS I, Chao Ming Zhao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Y. Tristan Kuo, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th (Principal Financial Officer)]

By info| 2016-04-03T02:07:04+00:00 May 8th, 2012|Categories: CBPO, Chinese Stocks, SEC Original|Tags: 0001369868, 10-Q, 2012-05-08, 2836, BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES), CBPO|0 Comments

CBPO [China Biologic Products] 10-Q: FORM 10Q (Mark One) For the quarterly period

[FORM 10Q (Mark One) For the quarterly period ended: March 31, 2012 [ ] For the transition period from ____________to _____________ CHINA BIOLOGIC PRODUCTS, INC. Delaware 75-2308816 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) 18th Floor, Jialong International Building Chaoyang District, Beijing 100125 (+86) 10-6598-3111 _____________________________________________________________________ (Former name, former address and former fiscal year, if] [CERTIFICATIONS I, Chao Ming Zhao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Y. Tristan Kuo, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th (Principal Financial Officer)]

By info| 2016-04-03T02:08:26+00:00 May 8th, 2012|Categories: CBPO, Chinese Stocks, Webplus ver|Tags: 0001369868, 10-Q, 2012-05-08, 2836, BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES), CBPO|0 Comments

CBPO [China Biologic Products] DEFA14A: (Original Filing)

[SCHEDULE 14A Check the appropriate box: [ ] Preliminary Proxy Statement [ ] [ ] Definitive Proxy Statement [X] Definitive Additional Materials [ ] Soliciting Material under Rule 14a-12 CHINA BIOLOGIC PRODUCTS, INC. ____________________________________________________________ Payment of Filing Fee (Check the appropriate box): [X] No fee required [ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.]

By info| 2016-04-03T02:09:49+00:00 April 30th, 2012|Categories: CBPO, Chinese Stocks, SEC Original|Tags: 0001369868, 2012-04-30, 2836, BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES), CBPO, DEFA14A|0 Comments

CBPO [China Biologic Products] DEFA14A: SCHEDULE 14A Check the appropriate box: [ ]

[SCHEDULE 14A Check the appropriate box: [ ] Preliminary Proxy Statement [ ] [ ] Definitive Proxy Statement [X] Definitive Additional Materials [ ] Soliciting Material under Rule 14a-12 CHINA BIOLOGIC PRODUCTS, INC. ____________________________________________________________ Payment of Filing Fee (Check the appropriate box): [X] No fee required [ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.]

By info| 2016-04-03T02:11:06+00:00 April 30th, 2012|Categories: CBPO, Chinese Stocks, Webplus ver|Tags: 0001369868, 2012-04-30, 2836, BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES), CBPO, DEFA14A|0 Comments

CBPO [China Biologic Products] DEF 14A: SCHEDULE 14A Check the appropriate box: [ ]

[SCHEDULE 14A Check the appropriate box: [ ] Preliminary Proxy Statement [ ] [X] Definitive Proxy Statement [ ] Definitive Additional Materials [ ] Soliciting Material under Rule 14a-12 CHINA BIOLOGIC PRODUCTS, INC. ____________________________________________________________ Payment of Filing Fee (Check the appropriate box): [X] No fee required [ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.]

By info| 2016-04-03T02:13:56+00:00 April 30th, 2012|Categories: CBPO, Chinese Stocks, Webplus ver|Tags: 0001369868, 2012-04-30, 2836, BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES), CBPO, DEF_14A|0 Comments

CBPO [China Biologic Products] 8-K: (Original Filing)

[China Biologic Has Announced the Resignation of CFO Y. Tristan Kuo and Named Mr. Ming Yang as Interim CFO BEIJING, China, April 27, 2012 /PRNewswire via COMTEX/ China Biologic Products, Inc. (NASDAQ: CBPO, “China Biologic” or the “Company”), one of the leading plasma-based biopharmaceutical companies in the People’s Republic of China, today announced the resignation of Chief Financial Officer, Mr.] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): April 26, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) No. 14 East Hushan Road, Taian City, Shandong, 271000 Peoples Republic of China 86-538 -620-2306 ____________________________________________________________ (Former name or former address, if changed]

By info| 2016-04-03T02:15:16+00:00 April 27th, 2012|Categories: CBPO, Chinese Stocks, SEC Original|Tags: 0001369868, 2012-04-27, 2836, 8-K, BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES), CBPO|0 Comments

CBPO [China Biologic Products] 8-K: China Biologic Has Announced the Resignation of CFO

[China Biologic Has Announced the Resignation of CFO Y. Tristan Kuo and Named Mr. Ming Yang as Interim CFO BEIJING, China, April 27, 2012 /PRNewswire via COMTEX/ China Biologic Products, Inc. (NASDAQ: CBPO, “China Biologic” or the “Company”), one of the leading plasma-based biopharmaceutical companies in the People’s Republic of China, today announced the resignation of Chief Financial Officer, Mr.] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): April 26, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) No. 14 East Hushan Road, Taian City, Shandong, 271000 Peoples Republic of China 86-538 -620-2306 ____________________________________________________________ (Former name or former address, if changed]

By info| 2016-04-03T02:16:20+00:00 April 27th, 2012|Categories: CBPO, Chinese Stocks, Webplus ver|Tags: 0001369868, 2012-04-27, 2836, 8-K, BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES), CBPO|0 Comments

CBPO [China Biologic Products] 8-K: (Original Filing)

[China Biologic’s Board Has Appointed Two New Independent Directors to Boost Corporate Governance BEIJING, China, April 25, 2012 /PRNewswire/ China Biologic Products, Inc. (NASDAQ: CBPO, “China Biologic” or the “Company”), one of the leading plasma-based biopharmaceutical companies in the People’s Republic of China, today announced that effective April 20, 2012, the Company’s Board of Directors (the “Board”) has appointed Mr.] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): April 20, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) No. 14 East Hushan Road, Taian City, Shandong, 271000 Peoples Republic of China 86-538 -620-2306 (Former name or former address, if changed since]

By info| 2016-04-03T02:17:41+00:00 April 25th, 2012|Categories: CBPO, Chinese Stocks, SEC Original|Tags: 0001369868, 2012-04-25, 2836, 8-K, BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES), CBPO|0 Comments

CBPO [China Biologic Products] 8-K: China Biologic’s Board Has Appointed Two New Independent

[China Biologic’s Board Has Appointed Two New Independent Directors to Boost Corporate Governance BEIJING, China, April 25, 2012 /PRNewswire/ China Biologic Products, Inc. (NASDAQ: CBPO, “China Biologic” or the “Company”), one of the leading plasma-based biopharmaceutical companies in the People’s Republic of China, today announced that effective April 20, 2012, the Company’s Board of Directors (the “Board”) has appointed Mr.] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): April 20, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) No. 14 East Hushan Road, Taian City, Shandong, 271000 Peoples Republic of China 86-538 -620-2306 (Former name or former address, if changed since]

By info| 2016-04-03T02:18:39+00:00 April 25th, 2012|Categories: CBPO, Chinese Stocks, Webplus ver|Tags: 0001369868, 2012-04-25, 2836, 8-K, BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES), CBPO|0 Comments